Non-small cell lung cancer – Basic Information

Go back

Non-small cell lung cancer is the most common form of lung cancer, accounting for the vast majority of cases worldwide. This disease develops when normal lung cells change and multiply out of control, often without causing noticeable symptoms until it has already spread to other parts of the body.

Understanding Non-Small Cell Lung Cancer

Non-small cell lung cancer, commonly known as NSCLC, represents about 80% to 85% of all lung cancer diagnoses. The name comes from how the cancer cells appear under a microscope. Unlike small cell lung cancer, where cells look tiny and round, non-small cell lung cancer cells are larger in size. This distinction is important because it helps doctors understand how the disease behaves and determine the best treatment approach.[1]

The disease typically grows more slowly than small cell lung cancer, which might sound like good news. However, this slower growth can be deceptive. Because NSCLC often develops without causing symptoms in its early stages, many people don’t realize they have it until the cancer has already spread beyond the lungs to other organs. This makes early detection extremely important for improving outcomes.[1]

There are three main types of non-small cell lung cancer, each named for the specific cells where the cancer begins. Adenocarcinoma is the most common type, making up about 40% of all NSCLC cases. This type usually forms in the outer areas of the lung, specifically in the mucus-producing cells that line the small airways called bronchioles. Adenocarcinoma affects both people who smoke and those who have never smoked, and it tends to grow more slowly than other lung cancer types.[2]

Squamous cell carcinoma, also called epidermoid carcinoma, accounts for 25% to 30% of NSCLC diagnoses. This type typically starts in the central part of the lungs, in the thin, flat cells that line the inside surfaces of the airways called bronchi. Squamous cell carcinoma is more closely associated with smoking than other lung cancer types. Before adenocarcinoma became the most common type, squamous cell carcinoma held that position.[2]

Large cell carcinoma is the least common of the three main types, representing only 10% to 15% of NSCLC cases. This cancer can develop in any part of the lung and tends to be more aggressive. It’s considered a diagnosis of exclusion, meaning doctors identify it when the cancer cells can’t be classified as adenocarcinoma or squamous cell carcinoma through standard testing methods.[2]

Less common types of non-small cell lung cancer include adenosquamous carcinoma, which has features of both adenocarcinoma and squamous cell carcinoma, and sarcomatoid carcinoma. These rare forms require specialized treatment approaches.[3]

Epidemiology: Who Gets Non-Small Cell Lung Cancer

Lung cancer has become a leading cause of cancer death worldwide, with approximately 230,000 new cases diagnosed annually in the United States alone. The death toll reaches about 135,000 patients per year in the United States. To put this in perspective, lung cancer causes more deaths than prostate, breast, brain, and colorectal cancer combined. It has become the most common cause of cancer deaths in men and the second most common in women.[4]

The vast majority of lung cancers, about 85%, fall into the non-small cell category. This means that for every 100 people diagnosed with lung cancer, roughly 85 will have NSCLC rather than small cell lung cancer. This high proportion makes NSCLC a significant public health concern requiring widespread awareness and prevention efforts.[2]

However, there is some encouraging news. The statistics show a declining trend in lung cancer deaths, largely due to successful anti-smoking campaigns and decreased tobacco use in the United States. This demonstrates that prevention efforts can make a real difference in reducing the burden of this disease.[4]

Age plays a significant role in NSCLC occurrence. The disease is much more common in older adults and is considered rare in people under the age of 45. This age pattern means that as populations around the world age, the number of people at risk for developing NSCLC continues to grow.[5]

The types of lung cancer seen in the United States and many other countries have changed over the past few decades. The frequency of adenocarcinoma has risen while squamous cell carcinoma cases have declined. This shift may be related to changes in cigarette design and smoking patterns over the years.[6]

Causes of Non-Small Cell Lung Cancer

Non-small cell lung cancer develops when normal cells in the lungs undergo changes that cause them to grow and multiply out of control. While experts understand the biological process, they don’t always know exactly why these changes happen in some people and not in others. The transformation from normal cells to cancer cells is complex and usually involves multiple factors working together over time.[1]

The disease occurs when epithelial cells, which form the inside lining of the lungs and airways, begin to reproduce rapidly and uncontrollably. These abnormal cells can develop into a mass called a tumor. When the tumor is malignant, meaning cancerous, it has the potential to stay in one place or spread to other parts of the body through blood vessels or lymphatic channels.[7]

At the cellular level, cancer develops through accumulated genetic changes or mutations that affect how cells grow, divide, and die. Normally, cells have built-in mechanisms that control these processes and repair damage. When these control mechanisms fail due to genetic changes, cells can begin the transformation into cancer. In NSCLC, these changes often occur in genes that regulate cell growth and division.[3]

Risk Factors: What Increases Your Chances

Smoking cigarettes is by far the most significant risk factor for developing non-small cell lung cancer. Around 80% of NSCLC cases are caused by smoking. The risk isn’t just about whether you smoke, but also about how much and for how long. The number of cigarettes you smoke each day combined with how many years you’ve been smoking determines your overall exposure. The earlier in life you begin smoking, the greater your risk becomes over time.[5]

⚠️ Important
While smoking low-tar cigarettes might seem like a safer option, there is no evidence that they lower the risk of lung cancer. The only way to truly reduce smoking-related lung cancer risk is to stop smoking completely. The risk does decrease with time after you stop smoking, but it takes years for this benefit to fully develop.

Exposure to secondhand smoke, also called passive smoking, also raises the risk of lung cancer. This means that even if you’ve never smoked yourself, being around people who smoke regularly can increase your chances of developing NSCLC. This is why many public health campaigns focus on creating smoke-free environments in homes, workplaces, and public spaces.[5]

Some people who have never smoked do develop lung cancer, which tells us that other factors beyond tobacco play a role. A family history of lung cancer can increase risk, suggesting that genetic factors contribute to susceptibility. If close relatives like parents or siblings have had lung cancer, your risk may be higher than someone without this family history.[1]

Workplace exposures to certain substances significantly increase lung cancer risk. Asbestos, a fibrous mineral once commonly used in construction and manufacturing, is a well-known cause of lung cancer. Workers in industries like construction, shipbuilding, and mining may have been exposed to asbestos, especially if they worked in these fields before safety regulations became stricter. The combination of asbestos exposure and smoking is particularly dangerous, multiplying the risk beyond what either factor would cause alone.[4]

Other workplace and environmental carcinogens that increase NSCLC risk include arsenic, chromium, nickel, uranium, beryllium, vinyl chloride, coal products, mustard gas, and certain other chemicals. Exposure to these substances might occur through breathing contaminated air or handling materials that contain them. Products using chloride and formaldehyde can also pose risks.[5]

Radon is a naturally occurring radioactive gas that can seep into homes from the ground. It’s colorless and odorless, so you can’t detect it without special testing. Constant exposure to high levels of radon increases lung cancer risk. Some geographic areas have higher natural radon levels than others, making home testing particularly important in these regions.[1]

Previous radiation therapy to the chest can increase the risk of developing lung cancer years later. This might affect people who received radiation treatment for other cancers, such as breast cancer or Hodgkin lymphoma. The radiation used to treat one cancer can, in some cases, contribute to the development of a new cancer in the exposed tissues.[4]

Having certain respiratory conditions can also elevate risk. People with pulmonary fibrosis, a condition where lung tissue becomes scarred and stiff, or COPD (chronic obstructive pulmonary disease), which includes conditions like emphysema and chronic bronchitis, have a higher chance of developing lung cancer. These conditions are often smoking-related themselves, which adds to the complexity of risk factors.[1]

Environmental pollution and drinking water with high levels of arsenic are additional risk factors that affect communities. Air pollution from vehicle exhaust, industrial emissions, and other sources contributes to lung cancer risk, especially in highly polluted urban areas.[5]

Symptoms: How NSCLC Affects the Body

One of the most challenging aspects of non-small cell lung cancer is that it may not cause any symptoms in its early stages. Many people feel completely normal while the cancer is developing. This is why regular screening for people at high risk is so important. When symptoms do appear, they can vary from person to person depending on the location and size of the tumor.[1]

A chronic cough is one of the most common symptoms of NSCLC. This isn’t just any cough, but one that doesn’t go away or gets worse over time. For people who already have a smoker’s cough, a change in the pattern or intensity of coughing can be a warning sign. The cough might become more persistent, more painful, or sound different than before.[2]

Coughing up blood, even small amounts, is a serious symptom that should prompt immediate medical attention. The blood might appear as streaks in the mucus or phlegm, or it might color the sputum pink or red. This happens when the tumor erodes into blood vessels in the airways.[1]

Chest pain or discomfort is another common symptom. The pain might be dull and constant or sharp and intermittent. It can worsen with deep breathing, coughing, or laughing. This pain occurs when the tumor grows large enough to press on surrounding structures or when cancer spreads to the chest wall or the membrane covering the lungs.[2]

Shortness of breath develops when the tumor blocks airways or causes fluid to accumulate around the lungs. Even simple activities like walking across a room or climbing a few stairs might leave someone feeling winded. This symptom tends to worsen gradually as the cancer progresses, making everyday activities increasingly difficult.[1]

Wheezing, a high-pitched whistling sound when breathing, can occur if the tumor partially blocks an airway. The narrowed passage causes air to make this distinctive sound as it moves in and out of the lungs. While wheezing can have many causes, new or persistent wheezing warrants medical evaluation.[2]

Hoarseness or changes in voice happen when the tumor affects the nerve that controls the voice box. The voice might sound raspy, strained, or weaker than usual. This change typically develops gradually and persists rather than coming and going like it would with a simple cold.[1]

Loss of appetite and unintentional weight loss are common in many cancers, including NSCLC. People might notice they’re not hungry or that food doesn’t taste the same. They might lose weight without trying, which happens as the cancer affects the body’s metabolism and uses up energy and nutrients.[2]

Tiredness or fatigue goes beyond normal exhaustion. This is a deep, persistent tiredness that doesn’t improve with rest. It can make even small tasks feel overwhelming. Cancer-related fatigue affects both physical and mental energy, making concentration difficult alongside physical weakness.[1]

When NSCLC spreads to other parts of the body, additional symptoms may develop. Bone pain or tenderness can occur if cancer spreads to bones. Headaches, dizziness, or balance problems might indicate spread to the brain. Yellowing of the skin, called jaundice, can happen if cancer reaches the liver. Swelling in the face or neck might result from tumors blocking blood flow in vessels near the lungs. Shoulder pain can occur with certain lung tumors that affect nerves in that area.[5]

Trouble swallowing, joint pain, nail problems, and weakness are other symptoms that can appear in advanced stages. Eyelid drooping on one side is a specific sign that can occur with tumors in the upper part of the lung that affect nearby nerves.[5]

Prevention: Reducing Your Risk

The most effective way to prevent non-small cell lung cancer is to never start smoking or to quit if you currently smoke. Given that smoking causes around 80% of lung cancer cases, avoiding tobacco use is the single most powerful prevention strategy. For people who smoke, quitting at any age provides benefits. The lungs begin to repair some damage once smoking stops, and cancer risk decreases over time, although it may take years to approach the level of someone who never smoked.[5]

Avoiding secondhand smoke is equally important. This means creating smoke-free environments at home and, when possible, avoiding places where smoking occurs. For children living with smoking parents, exposure to secondhand smoke increases their future risk of developing lung cancer, making household smoking policies a family health issue.[5]

Testing your home for radon is a simple prevention step that many people overlook. Radon test kits are available at hardware stores and are easy to use. If high radon levels are detected, mitigation systems can be installed to reduce exposure. This is particularly important in geographic areas known to have elevated natural radon levels.[1]

Workplace safety measures protect against occupational exposures to cancer-causing substances. If you work in industries where exposure to asbestos, arsenic, chromium, or other carcinogens might occur, following safety protocols is essential. This includes wearing appropriate protective equipment, using proper ventilation, and following handling procedures for hazardous materials.[4]

For people at high risk of lung cancer, screening with low-dose CT scans may be recommended. High-risk groups typically include current or former heavy smokers between certain ages. Screening doesn’t prevent cancer but can detect it at earlier, more treatable stages. Healthcare providers can assess whether screening is appropriate based on individual risk factors.[2]

Maintaining overall health through a balanced diet and regular physical activity may provide some protective benefits. While these lifestyle factors aren’t as directly linked to lung cancer prevention as avoiding smoking, they support overall immune function and health. Eating fruits and vegetables provides antioxidants and other compounds that may help protect cells from damage.[1]

How the Disease Changes the Body: Pathophysiology

To understand how non-small cell lung cancer affects the body, it helps to know how healthy lungs work. The lungs are a pair of cone-shaped organs in the chest that bring oxygen into the body when you breathe in and release carbon dioxide, a waste product, when you breathe out. Each lung has sections called lobes. The left lung has two lobes while the right lung has three. Tubes called bronchi lead from the windpipe to each lung, branching into smaller tubes called bronchioles. At the ends of these tiny tubes are air sacs called alveoli, where oxygen enters the bloodstream.[3]

A thin membrane called the pleura covers the outside of each lung and lines the inside wall of the chest cavity. This creates a sac called the pleural cavity, which normally contains a small amount of fluid that helps the lungs move smoothly during breathing. All these structures can be affected as NSCLC develops and progresses.[3]

NSCLC begins when cells in the lungs undergo genetic changes that disrupt normal growth controls. These changes, called mutations, cause cells to divide when they shouldn’t and to avoid the natural death process that normally removes old or damaged cells. As these abnormal cells multiply, they form a mass or tumor. The tumor grows larger over time, taking up space in the lung and interfering with normal lung tissue.[7]

As the tumor grows, it can block airways, making it harder for air to move in and out of the lungs. This blockage reduces the amount of oxygen that reaches the blood and makes breathing more difficult. The tumor might also cause inflammation in surrounding tissues, leading to coughing and chest pain.[1]

Cancer cells can break away from the original tumor and travel through the bloodstream or lymphatic system to other parts of the body. This process is called metastasis. The lungs have an extensive network of blood vessels and lymph channels, which unfortunately makes it relatively easy for cancer cells to spread. Common sites where NSCLC spreads include the adrenal glands, bones, brain, liver, and lymph nodes.[1]

When NSCLC spreads to bones, cancer cells disrupt normal bone structure, causing pain and making bones more likely to break. In the brain, tumors can cause headaches, seizures, or changes in thinking and behavior by pressing on brain tissue. Liver metastases can interfere with the liver’s ability to process waste products and make proteins, leading to jaundice and other complications.[5]

Tumors can also cause fluid to accumulate around the lungs in the pleural cavity. This condition, called pleural effusion, compresses the lung and makes breathing even more difficult. The fluid must sometimes be drained to relieve symptoms and improve breathing.[1]

NSCLC affects the body’s metabolism in multiple ways. Cancer cells use large amounts of energy and nutrients as they grow rapidly, which can lead to weight loss and muscle wasting even when someone is eating normally. The cancer may also produce substances that affect appetite and how the body processes food.[2]

The immune system tries to fight cancer, but lung cancer cells can develop ways to evade immune detection and destruction. They might produce substances that suppress immune responses or display surface proteins that prevent immune cells from recognizing them as abnormal. This is why some newer treatments work by helping the immune system better recognize and attack cancer cells.[2]

Ongoing Clinical Trials on Non-small cell lung cancer

  • Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium Czechia France Germany Italy The Netherlands +3
  • Study of Tislelizumab, LBL-007, and BGB-15025 in Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    France Italy Romania Spain
  • Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Belgium Bulgaria Croatia Czechia Estonia Finland +14
  • Study on Brigatinib, Ceritinib, and Alectinib for Patients with Advanced ALK+ Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Germany
  • Study on Additional Chemotherapy with Osimertinib, Carboplatin, and Cisplatin for Patients with Advanced Non-Small Cell Lung Cancer and EGFR Mutation

    Not recruiting

    1 1 1
    Investigated diseases:
    Germany
  • Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria France Hungary Italy The Netherlands Poland +2
  • Study of Tiragolumab and Atezolizumab for Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Germany Greece Hungary Italy The Netherlands +2

References

https://my.clevelandclinic.org/health/diseases/6203-non-small-cell-lung-cancer

https://www.yalemedicine.org/conditions/non-small-cell-lung-cancer

https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq

https://www.ncbi.nlm.nih.gov/books/NBK562307/

https://medlineplus.gov/ency/article/007194.htm

https://emedicine.medscape.com/article/279960-overview

https://www.dana-farber.org/cancer-care/types/non-small-cell-lung-cancer

FAQ

Can non-smokers get non-small cell lung cancer?

Yes, some people who have never smoked do develop non-small cell lung cancer. While smoking is the leading cause, other risk factors like secondhand smoke exposure, radon gas, family history, workplace carcinogens, and environmental pollution can contribute to NSCLC development in non-smokers. Adenocarcinoma is the type most commonly found in people who have never smoked.

What’s the difference between NSCLC and SCLC?

The main differences lie in how the cells look under a microscope and how they behave. Small cell lung cancer (SCLC) cells appear small and round, while non-small cell lung cancer (NSCLC) cells are larger. SCLC is generally more aggressive and grows faster than NSCLC. However, NSCLC is more common, accounting for 80-85% of all lung cancer cases. These differences affect treatment approaches and prognosis.

Why doesn’t NSCLC cause symptoms in early stages?

In early stages, NSCLC tumors are often small and located in areas of the lung that don’t have many nerve endings. The lungs have significant reserve capacity, meaning a small tumor might not affect breathing noticeably. Symptoms typically appear only when the tumor grows large enough to block airways, press on other structures, or spread to areas that do cause noticeable effects. This is why screening for high-risk individuals is important.

What is adenocarcinoma and why is it the most common type?

Adenocarcinoma is a type of NSCLC that begins in the mucus-producing cells lining the small airways in the outer areas of the lungs. It represents about 40% of all NSCLC cases, making it the most common type. Adenocarcinoma tends to grow more slowly than other types and affects both smokers and non-smokers. Changes in cigarette design and smoking patterns over the decades may have contributed to its increased frequency compared to squamous cell carcinoma.

Does quitting smoking reduce lung cancer risk if you’ve smoked for years?

Yes, quitting smoking at any age provides benefits and reduces lung cancer risk over time. The lungs begin repairing some damage once smoking stops, and cancer risk decreases with each smoke-free year, although it may take many years to approach the level of someone who never smoked. The risk never completely disappears if you were a heavy smoker, but it does decline significantly compared to continuing to smoke.

🎯 Key takeaways

  • Non-small cell lung cancer accounts for about 80-85% of all lung cancer cases, making it by far the most common type of lung cancer worldwide.
  • Smoking causes around 80% of NSCLC cases, but importantly, some people who never smoked also develop this disease due to other risk factors.
  • NSCLC often grows silently without symptoms in early stages, which is why it’s frequently diagnosed only after spreading to other body parts.
  • The three main types—adenocarcinoma, squamous cell carcinoma, and large cell carcinoma—differ in where they start and how they grow.
  • Radon gas, a naturally occurring radioactive substance that can accumulate in homes, is a significant but often overlooked lung cancer risk factor.
  • Workplace exposures to substances like asbestos, arsenic, and chromium substantially increase lung cancer risk, especially when combined with smoking.
  • Common symptoms include persistent cough, chest pain, shortness of breath, and coughing up blood, though these often appear only in later stages.
  • Prevention focuses primarily on never starting smoking or quitting if you smoke, along with avoiding secondhand smoke and testing homes for radon.

Connected medications: